Muscolo - Skeletal System

{loadposition position-9}

{loadposition position-7}



ATC Reimbursed

List of reimbursed drugs, is an important part of Service Packages covering the Fund of Compulsory Health Care Insurances for the population. The list of reimbursable drugs aims at improving the quality of service for all patients, particularly for people in need. In this regard, through the new list of drugs, FCHC aims at increasing the attention toward categories such as retirees and patients suffering from serious illnesses.

In compiling the list of drugs there are some scientific criteria which have been taken into consideration, by giving priority to drugs used for severe diseases; diseases of high risk for life; diseases that cause disability; diseases that risk of being spread into the society; diseases that cause much suffering as well as chronic illnesses requiring prolonged treatment.

Muscolo - Skeletal System - Reimbursed

Tablets - 300mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (uratenephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Tablets – 100 mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (urate nephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Granules for oral suspension - 100 mg

Cox-in contains the active substance nimesulide. It belongs to a group of medicines called non-steroidal antiinflammatory drugs (NSAIDs) and has analgesic properties.

Cox-in is used for the treatment of acute pain and menstrual pain.

Nimesulide should only be prescribed as second-line treatment.

Solution for injection - 160 mg / 2 ml

Dolomed contains the active substance ketoprofen lysine.

Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory drug (NSAID).

Dolomed is indicated in:

  • the treatment of acute exacerbations of musculoskeletal, joint, articular, peri-articular and soft tissue disorders;

the management of pain after orthopaedic surgery.

Gel - 1%

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

 

Solution for injection - 75 mg / 3 ml

 

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

Suppositories - 100 mg

Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.

Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).

Durilac is used:

  • in musculo-skeletal disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis;
  • in peri-articular disorders such as bursitis and tendinitis;
  • in soft-tissue disorders such as sprains and strains;
  • in painful conditions such as renal colic, acute gout, dysmenorrhoea;
  • after some surgical procedures.

 

Granules for oral solution

 

Granules for oral solution - 40 mg

 

Suppositories – 75 mg

Suppositories – 150 mg

Film coated tablets - 600 mg

 

Oral suspension - 100 mg / 5 ml

 

Film coated tablets - 400 mg

 

Film coated tablets - 400 mg

 

Gel - 2.5 %

 

Suppositories - 100 mg

Indomethacin belongs to the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These drugs are soothing pain medications and reduce swelling (inflammation) with all its signs.

Indometacine suppositories can be used for:

  •  inflammatory diseases of the joints or surrounding tissues such as rheumatoid arthritis,  osteoarthritis and degenerative diseases of the coxo-femoral joint;
  •   deformation and stiffness of spinal cord (ankylosing spondylitis);
  •   muscle pain, back pain and pain coming from the bones;
  •   menstrual pain;
  •   gout.

Solution for injection - 30 mg/ ml

 

Tablets - 70 mg

Solution for injection - 4 mg / 2 ml

Pancuron contains the active substance pancuronium bromide.

Pancuron is a long-acting non-depolarising muscle relaxant, also known as non-depolarising neuromuscular blocking agent.

Pancuron solution for injection is used for muscle relaxation in general anaesthesia.

 

Results 1 - 20 of 24